These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32153053)

  • 1. Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.
    Chiu T; Brett J; Pearson SA; Schaffer AL
    Br J Clin Pharmacol; 2020 Sep; 86(9):1882-1887. PubMed ID: 32153053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings.
    Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA
    Addiction; 2019 Jun; 114(6):1026-1034. PubMed ID: 30098227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use.
    Schaffer AL; Brett J; Buckley NA; Pearson SA
    Pain; 2022 May; 163(5):e614-e621. PubMed ID: 34382609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
    Kaul I; Amin A; Rosenberg M; Rosenberg L; Meyer WJ
    Burns; 2018 Mar; 44(2):414-422. PubMed ID: 28822592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment.
    Wettermark B; Brandt L; Kieler H; Bodén R
    Int J Clin Pract; 2014 Jan; 68(1):104-10. PubMed ID: 23815622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial.
    Jung JM; Chung CK; Kim CH; Yang SH; Choi Y
    Sci Rep; 2020 May; 10(1):8120. PubMed ID: 32415211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy.
    Kozma CM; Benson C; Slaton TL; Kim MS; Vorsanger GJ
    Curr Med Res Opin; 2012 Sep; 28(9):1485-96. PubMed ID: 22856535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration.
    Sakai Y; Ito K; Hida T; Ito S; Harada A
    Eur Spine J; 2015 Jun; 24(6):1309-17. PubMed ID: 25682273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
    Karanges EA; Blanch B; Buckley NA; Pearson SA
    Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration.
    Freynhagen R; Baron R; Kawaguchi Y; Malik RA; Martire DL; Parsons B; Rey RD; Schug SA; Jensen TS; Tölle TR; Ushida T; Whalen E
    Postgrad Med; 2021 Jan; 133(1):1-9. PubMed ID: 33423590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operant self-administration of pregabalin in a mouse model of neuropathic pain.
    Bura SA; Cabañero D; Maldonado R
    Eur J Pain; 2018 Apr; 22(4):763-773. PubMed ID: 29280233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study.
    Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):97-105. PubMed ID: 30421838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.
    Cardenas DD; Emir B; Parsons B
    Clin Ther; 2015 May; 37(5):1081-90. PubMed ID: 25850879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.
    Schug SA; Parsons B; Almas M; Whalen E
    Pain Physician; 2017; 20(1):E53-E63. PubMed ID: 28072797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan.
    Hirakata M; Yoshida S; Tanaka-Mizuno S; Kuwauchi A; Kawakami K
    Pain Res Manag; 2018; 2018():2786151. PubMed ID: 29973966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K.
    Berger A; Sadosky A; Dukes E; Edelsberg J; Oster G
    Pain Pract; 2009; 9(1):18-34. PubMed ID: 19019054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin prescribing patterns in Australian general practice, 2012-2018: a cross-sectional study.
    Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S
    BJGP Open; 2021 Jan; 5(1):. PubMed ID: 33172853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?
    Pérez C; Latymer M; Almas M; Ortiz M; Clair A; Parsons B; Varvara R
    Pain Pract; 2017 Apr; 17(4):470-479. PubMed ID: 27589095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.